Too much vitamin B3 may contribute to heart disease, study finds.


Consuming too much niacin may be bad for the heart.

  • There are several non-modifiable and preventable risk factors for heart disease.
  • Researchers recently found that high levels of a common B vitamin called niacin in the body may contribute to cardiovascular disease.
  • They saw that excess niacin can trigger vascular inflammation, which in turn may lead to atherosclerosis — or plaque buildup on artery walls.

About 20.5 million people around the world died from cardiovascular disease in 2021, making it responsible for a third of all deaths globally.

While there are some unmodifiable risk factors for heart disease, including genderTrusted Source, family historyTrusted Source, and ethnicityTrusted Source, there are several preventable causes for cardiovascular disease, including obesityTrusted Source, high cholesterol levelsTrusted Source, high blood pressureTrusted Source, smokingTrusted Source, eating an unhealthy dietTrusted Source, and not getting enough physical activityTrusted Source.

Now, researchers from the Cleveland Clinic Lerner Research Institute have added to the list of potentially modifiable risk factors with a new study reporting high levels of a common B vitamin called niacin in the body may contribute to cardiovascular disease.

The study was recently published in the journal Nature MedicineTrusted Source.

Searching for new heart disease pathways

Finding a potential link between niacin and heart disease was not the original intention of this study, Dr. Stanley Hazen, The Jan Bleeksma Chair in Vascular Cell Biology and Atherosclerosis, director of the Center for Cardiovascular Diagnostics & Prevention, and director of the Center for Microbiome & Human Health at the Cleveland Clinic Lerner Research Institute, and lead author of this study told Medical News Today.

“Our initial goal was to identify new pathways that contribute to heart disease. Even when treating cardiovascular disease risk factors to goal (e.g. cholesterol, blood pressure, diabetes, etc.), the majority of events (heart attack, stroke, death) continue to occur, or at best, we reduce the event rate by 50%. This means there are other pathways we are not addressing,” Dr. Hazen explained.

Dr. Hazen said he and his team were looking for compounds in the blood that might contribute to the future development of heart attack, stroke, or death independent of traditional risk factors.

“The compound 4PYTrusted Source was identified that is linked to future CVD events — in a U.S. cohort initially, then replication in a U.S. cohort, and further validation in a European cohort,” he continued.

“We then performed preclinical studies (animal model) and cell-based studies — all of which showed this compound contributes to vascular inflammation. 4PY, it turns out, is a breakdown product made from excess niacin,” he told MNT.

What is niacin? 

Niacin — also known as vitamin B-3 — is one of eight different B vitamins.

Niacin helps the body convert foods eaten into energy. It also helps keep the skin healthyTrusted Source and the nervous systemTrusted Source running smoothly.

As the body cannot make niacin, it needs to get it from the foods we eat or via a supplement.

For example, the body convertsTrusted Source the amino acid tryptophanTrusted Source — found in most animal products, including meat and dairy — into niacin.

Niacin can also naturally be found in legumes, whole grains, nuts, and seeds. And there are also some foods, such as cereals and breads, fortified with niacin.

The body does not store niacin — any excess not used is removed from the body via urine.

Higher levels of 4PY associated with adverse cardiac event

For this study, Dr. Hazen and his team studied the fasting plasma from about 1,100 people with stable cardiac health.

Upon analysis, researchers discovered that higher circulating levels of N1-methyl-4-pyridone-3-carboxamide, or 4PY, were strongly associated with the development of a heart attack, stroke, or other unhealthy cardiac events.

“Our studies found high levels of 4PY in the blood predict future cardiac disease. These new studies help identify a new pathway that contributes to heart disease,” Dr. Hazen said.

However, Dr. Hazen said the main takeaway for readers is not that we should cut out our entire intake of niacin — that’s not a realistic or healthy approach.

OTC niacin supplements

“Given these findings, a discussion over whether a continued mandate of flour and cereal fortification with niacin in the U.S. could be warranted. Patients should consult with their doctors before taking over-the-counter supplements and focus on a diet rich in fruit and vegetables while avoiding excess carbohydrates.”
— Dr. Stanley Hazen

Excess 4PY triggers vascular inflammation

Scientists also found that 4PY directly triggers vascular inflammation, which can damage blood vessels and lead to a buildup of plaque on artery walls, known as atherosclerosis.

“Atherosclerosis is caused by both high cholesterol and inflammation. We know how to treat the high cholesterol side of the equation, but not the inflammation side. This pathway appears to be a major participant in vascular inflammation,” Dr. Hazen said.

“(Our) research uncovered that excess niacin fuels inflammation (and) cardiovascular disease through a newly discovered pathway. (These) findings are significant because they provide a foundation for potential new interventions and therapeutics to reduce or prevent inflammation.”
— Dr. Stanley Hazen

Dr. Hazen said that now with the discovery of this link, there is much more research to do.

“On the one hand, we need to explore what other cardiovascular diseases/phenotypes are linked to 4PY since vascular inflammation is a fundamental contributor to many diseases/phenotypes — e.g. heart failure, stroke, (and) other forms of vascular disease,” he explained.

“Beyond this, we then want to focus on how to disrupt this pathway to leverage the newly gained knowledge to develop a therapeutic,” he added.

Should I stop using niacin supplements?

MNT also spoke with Dr. Cheng-Han Chen, a board certified interventional cardiologist and medical director of the Structural Heart Program at MemorialCare Saddleback Medical Center in Laguna Hills, CA, about this study.

“This study identifies excess niacin, specifically its breakdown metabolite 4PY, as a risk factor for major adverse cardiovascular events such as heart attack and stroke,” Dr. Chen explained.

“While niacin was previously prescribed as acholesterol-lowering medicationTrusted Source, its use has fallen out of favor as multiple studies did not find as much benefit to cardiovascular health as initially thought. This study will put another nail in the coffin for the use of niacin in heart disease.”
— Dr. Cheng-Han Chen

Dr. Chen said more studies need to be performed to better understand the dose relationship between niacin supplementation and cardiovascular disease.

“For now, I would caution against routine intake of niacin supplements in the average person,” he continued. “It may be more difficult, however, to avoid niacin-fortified foods given its ubiquity in the food chain; niacin fortification may need to be examined at a higher level as a matter of public policy.”

High dietary niacin intake associated with decreased likelihood of COPD


Key takeaways:

  • Preliminary results suggest vitamin B3 may protect against COPD.
  • More research is needed to determine the optimal dosage and timing of dietary niacin to enhance lung function and prevent COPD.

Higher dietary niacin intake was associated with reduced COPD prevalence in adults, according to a study published in Scientific Reports.

Wen-Wen Li, from Dongying People’s Hospital in China, and colleagues pointed to previous research showing “that certain vitamins, notably vitamins A, C, D and E, have a positive impact on COPD.”

PC0224Li_Graphic_01_WEB

“These vitamins can be ingested either as supplements or through a well-balanced diet,” they wrote, although the relationship between vitamin B3, or niacin — found in foods like meat, nuts and fish — and COPD “remains unexplored.”

The researchers assessed possible correlations between dietary niacin intake and COPD using data from adults enrolled the National Health and Nutrition Examination Survey between 2003 and 2012.

The adults were then divided into COPD (n = 243) or non-COPD (n = 6,812) groups.

Compared with the non-COPD group, those with COPD were older and had a lower daily mean dietary niacin intake (21.39±0.62 mg vs. 25.29±0.23 mg).

Li and colleagues found that those in the highest quartile of dietary niacin intake had decreased odds of COPD compared with those in the lowest quartile (OR = 0.55; 95% CI, 0.33-0.89).

The results “suggest that niacin could serve as a protective factor against the onset of COPD,” they said, although the mechanisms are still not fully understood.

“Research indicates that niacin and its primary metabolite have antioxidant and anti-inflammatory effects,” they wrote. “Given these properties, niacin is likely to aid in preventing COPD by reducing inflammation in the airways, protecting them from oxidative damage, and improving their overall functionality.”

The study had several limitations. For example, the researchers could not determine causality, and the food frequency questionnaire that patients completed may have been vulnerable to misclassification and recall bias.

Ultimately, “further research is required to ascertain whether niacin as an alternative therapy can enhance lung ventilation function and effectively prevent COPD,” Li and colleagues concluded. “Additionally, there is a need for more detailed studies to establish the optimal dosage and timing for niacin’s potential beneficial effects on COPD.”

Niacin: The Real Story


Niacin (vitamin B3) is a biomolecule required by all forms of life. It functions as a precursor to NAD, an enzymatic co-factor in hundreds of metabolic pathways. Niacin is called a vitamin because the body can only synthesize it slowly and therefore requires a small but adequate amount from the diet. The reason that we cannot synthesize adequate amounts of niacin can be traced back to evolutionary pressure. Over millions of years, niacin was readily available from plant- and animal-based foods, so our bodies have evolved to rely on this dietary source.  However, larger amounts of niacin than the minimum required by the body are helpful because they allow our metabolic pathways to function at full speed for optimal health and to prevent disease. Some individuals are dependent upon high levels of niacin for health because of their genetic background or because of severe stress. For these individuals, much higher doses of niacin than the minimum dose can prevent and reverse disease. And for the rest of us, high doses of niacin are beneficial — and even necessary — for many aspects of health.

This new expanded edition nearly doubles the original Niacin: The Real Story, (from 228 to now 490 pages). It has several new chapters and appendices and more than 600 references to document recent advances in scientific knowledge about niacin. Several chapters focus on the different forms of the molecule niacin, how it works, safety of niacin supplements, and how to take niacin supplements. Other chapters describe how niacin can help to prevent and reverse a variety of diseases and other conditions, including arthritis, ADHD, many forms of mental illness, cardiovascular disease, aging, alcoholism, Alzheimer’s, cancer, cholera, Huntingdon’s disease, migraine, multiple sclerosis, nephritis (kidney inflammation), Parkinsonism, PTSD, Raynaud’s disease, and a variety of skin conditions. There is a special chapter focused on the recent COVID-19 pandemic: how niacin can help the body recover from infection and reduce the risk of “Long COVID.”

A major focus of the book is how niacin supplements, along with adequate doses of all the other essential nutrients (vitamins and minerals) and a healthy diet that avoids sugar and processed foods, can prevent and even reverse a variety of diseases. This orthomolecular theme is developed in the chapter “Pandeficiency Disease.” This theme is based on avoiding deficiencies of vitamins and minerals that contribute to a wide variety of conditions. Some vitamins are needed only in small milligram or microgram daily doses, but others such as vitamin C and niacin are needed in much higher doses, depending on the body’s state of stress, inflammation, and disease. The optimal dose varies with the individual and the state of inflammation and disease because biochemical stress in the body can deplete vitamin and cause deficiencies — which in turn can cause many different types of disease.

The book contains several interesting and significant new sections and chapters. The chapter entitled “Reversing Arthritis with Niacinamide” has been expanded, now including some of Dr. Kaufman’s notes and a memoir written up as his final unpublished paper. Niacin: The Real Story is the only book in print to present Kaufman’s own case notes and niacinamide protocol details. In these new sections, Dr. Kaufman documents his discovery of niacin and niacinamide treatments during his medical education, along with his observations of the nutritional deficiencies in the typical diet that caused pellagra (caused by a severe deficiency of niacin) and that also tended to cause osteoarthritis.

Many of the patients in the early years of his practice in the 1940s were referred by other physicians who wanted to get rid of their most complaining and difficult patients. At the time, the only treatments for arthritis were aspirin, hot paraffin dips, or heat treatment of joints. With his careful observations of symptomatology, Kaufman realized that most had a niacin deficiency — and these symptoms are summarized in detail. He explains that he soon found that most of these patients had a deficiency of niacin in their diets — proven by rapid improvement after niacinamide treatment. He reported that he treated all his patients with kindness, respect, and adequate doses of niacinamide — and soon after starting niacinamide treatment with up to 2000 mg or more per day, taken in divided doses, the patients “became easy to take care of medically” and had “astonishing improvements in their health.” Kaufman took their complaints seriously and found that a niacin deficiency was independent of family income. Well-to-do families could afford a nutritionally good diet, even if they did not do so.

Although by 1940 enriched flour was fortified with thiamine, niacin, riboflavin and iron, Kaufman realized that for most individuals, the doses of these essential nutrients from foods made with enriched flour were inadequate. So his treatment with adequate doses of niacinamide became more widely appreciated and soon his practice was full. Patients recovered with a “high degree of wellness and maintained this as long as they continued taking niacinamide.”

The new section on Erectile Dysfunction may interest many readers. Adequate doses of niacin taken long-term can help to prevent atherosclerosis, hyperlipidemia, and related coronary disease, and it also is a vasodilator. Because niacin (but not niacinamide) normalizes blood lipids, its long-term circulatory benefits may facilitate a male’s erection. While the vasodilation produced by niacin is not as long as produced by ED drugs, the niacin flush typically lasts about half an hour.  But since niacin also helps to improve mood and possibly sexual interest, generally the sense of calmness from a goodly dose of niacin may tend to diminish passion. In a related topic, adequate doses of niacin and the consequential flush that dilates blood vessels have been employed by people to ameliorate Raynaud’s syndrome (cold hands and feet due to reduced blood flow).

There are several new Appendices, including “An Interview with Abram Hoffer, MD, PhD.” Hoffer, a brilliant doctor and scientist, explains that he successfully treated thousands of schizophrenia patients with niacin. He also had excellent success treating depression, and showed that niacin lowered total cholesterol. Hoffer then explains that niacin is not dangerous or toxic at tolerable doses, and that adequate doses of vitamins (in particular, niacin) produce a recovery rate of 90 percent in schizophrenics.

Niacin is a vitamin, not a drug. Each individual may require a different daily dose. Dr. Hoffer says: “A person’s upper limit is that amount which causes nausea, and, if not reduced, vomiting. The dose should never be allowed to remain at this upper limit. The usual dose range is up to 3,000 mg daily, divided into three doses, but occasionally some patients may need more. The toxic dose for dogs is about 5,000 milligrams per 2.2 pounds (1 kilogram) body weight. We do not know the toxic dose for humans since niacin has never killed anyone.” But what about that “niacin flush”? “Most people flush when they first start taking high doses and gradually get adapted to it, unless they stop for a few days and then resume. A few cannot ever get used to it and take no-flush niacin. The intensity of the flush is variable. Generally the people who need it the most flush the least. That includes arthritics, schizophrenics, and elderly people with cardiovascular disease. Some schizophrenics do not flush until they get well — and then they do. But the presence of the flush or its intensity can not be uniquely used measure the need as there are too many variables such as food in the stomach, whether the drink with it is hot or cold, the kind of food, other medication. Antipsychotics reduce the intensity of the flush as do aspirin and antihistamines.”

In this revised edition of Niacin: The Real Story, authors Hoffer, Foster, and Saul clearly present the practical details of niacin treatment. Inevitable physician skepticism, and questions about niacin’s proven safety and effectiveness, are thoroughly addressed in this book. However, this is NOT a biochemistry textbook — to most of us, that is a relief. But since even a basic working knowledge of niacin can profoundly improve the health of so many patients, this vitamin becomes very interesting very quickly.

The book provides vitamin dose protocols and a chapter on safety of niacin, to assist you in learning the proper doses along with supplements of other vitamins and minerals. It explains that by taking niacin at appropriate daily doses, you can prevent and reverse osteoarthritis (the most common form), elevated cholesterol and cardiovascular disease, and several types of mental illness including schizophrenia. You can determine the correct dose by starting at a very low dose, 20 mg (milligrams) per day, and then gradually increasing the dose over several weeks up to 1000 mg/day or more in divided doses. The skin flush that comes with taking a large niacin dose gradually disappears over several weeks. The flush can be avoided by replacing the niacin dose with niacinamide — but this doesn’t help to correct high cholesterol as does niacin.

HPS2-THRIVE: Niacin therapy not beneficial for vascular disease.


Niacin, in combination with laropiprant, appears to provide no benefit and may have harmful effects in patients with vascular disease, researchers reported.

The 4-year HPS2-THRIVE study tested a combination of extended-release niacin 2 g plus laropiprant 40 mg (Tredaptive, Merck) compared with placebo in 25,673 patients at risk for CV events. In addition, all patients received simvastatin (Zocor, Merck), with or without ezetimibe (Zetia, Merck).

According to results presented at a late-breaking clinical trials session, the study did not meet the primary endpoint of reducing risk for a major vascular event, defined as a composite of nonfatal MI or CV-related death, stroke, or need for angioplasty or bypass surgery. Patients assigned extended-release niacin/laropiprant had a similar number of major vascular events compared with patients assigned placebo (13.2% vs. 13.7%; P=.29).

The extended-release niacin/laropiprant had increased rates of excess bleeding (2.5% vs. 1.9%) and infections (8% vs. 6.6%). In addition, serious adverse events were more prevalent with combination therapy, including new-onset diabetes (9.1% vs. 7.3%), diabetic complications (11.1% vs. 7.5%), indigestion and diarrhea (4.8% vs. 3.8%) and rashes (0.7% vs. 0.4%).

Data by the HPS2-THRIVE Collaborative Group published in European Heart Journal in early March revealed that by the end of the study 25% of patients assigned combination therapy had stopped treatment compared with 17% of patients assigned placebo.

“A striking finding from the study was a significant excess [in adverse events] among people who were allocated the niacin preparation. The excess represents a 3% absolute excess, which means 30 patients for every 1,000 treated patients had at least one side effect,” Jane Armitage, FFPH, FRCP,professor at the University of Oxford, United Kingdom, said at a press conference.

“It was a disappointing result but, nevertheless, these are clear and reliable results from a large study.”

 

PERSPECTIVE

 

Christie M. Ballantyne

  • We confirmed that using niacin in well-treated patients on statins with low LDL does not have a benefit. That was a very common use for this medicine. The other important point this study nails down is that the adverse effects of niacin in extended release were considerable. If we are going to use the drug in patients with high LDL, we have to think about the modest benefits and risks.
  • Christie M. Ballantyne, MD
  • Professor of Medicine
    Baylor College of Medicine

    • Source: Endocrine Today.